| TMH | tetramethylammonium hydroxide |
|---|---|
| NPH | 1) Neutral Protamine Hagedorn Insulin = Isophane Insulin Susp... |
| ACM | acetaminophen; acute cerebrospinal meningitis; Adriamycin, cyclophosphamide, methotrexate; albumin- ... |
| AS | acetylstrophanthidin; acidified serum; acoustic schwannoma; acoustic stimulation; active sarcoidosis... |
| CMF | calcium-magnesium free; catabolite modular factor; chondromyxoid fibroma; Christian Medical Fellowsh... |
| craniofacial suspension wiring | A method of wiring using areas of bones not contiguous with the oral cavity for the support of fractured jaw segments (e.g., pyriform aperture, zygomatic arch, zygomatic process of the frontal bone). (05 Mar 2000) |
|---|---|
| crystalline insulin zinc suspension | A long-acting insulin suspension, obtained from beef, with an approximate time of onset of 7 hours and a duration of action of 36 hours. Synonym: crystalline insulin zinc suspension. (05 Mar 2000) |
| prompt insulin zinc suspension | Sterile suspension of insulin in buffered water for injection, modified by the addition of zinc chloride such that the solid phase of the suspension is amorphous; it contains 40 or 80 units per ml; the duration of action is equivalent to that of insulin injection. Synonym: amorphous insulin zinc suspension, semilente insulin. (05 Mar 2000) |
| Sayre's suspension apparatus | Archaic term for Sayre's suspension traction. (05 Mar 2000) |
| Sayre's suspension traction | Spinal traction obtained by vertical suspension of the patient by means of a head halter. (05 Mar 2000) |
| hindlimb suspension | Technique for limiting use, activity, or movement by immobilizing or restraining animal by suspending from hindlimbs or tails. This immobilization is used to simulate some effects of reduced gravity and study weightlessness physiology. (12 Dec 1998) |
| suspension | 1. A condition of temporary cessation, as of animation, of pain or of any vital process. 2. <pharmacology> A preparation of a finely divided drug intended to be incorporated (suspended) in some suitable liquid vehicle before it is used or already incorporated in such a vehicle. Origin: L. Suspensio (18 Nov 1997) |
| suspension colloid | A colloidal solution in which the disperse particles are solid and lyophobe or hydrophobe, and are therefore sharply demarcated from the fluid in which they are suspended. Synonym: hydrophobic colloid, lyophobic colloid, suspension colloid. Origin: suspension + G. Eidos, resemblance (05 Mar 2000) |
| suspension stability | A very slow sedimentation rate. (05 Mar 2000) |
| insulin zinc suspension | A sterile buffered suspension with zinc chloride, containing 40 or 80 units per ml; the solid phase of the suspension consists of a mixture of 7 parts of crystalline insulin and 3 parts of amorphous insulin. Synonym: lente insulin. (05 Mar 2000) |
| extended insulin zinc suspension | A long-acting insulin suspension, obtained from beef, with an approximate time of onset of 7 hours and a duration of action of 36 hours. Synonym: crystalline insulin zinc suspension. (05 Mar 2000) |
| aluminum magnesium silicate | An antacid. Synonym: aluminum magnesium silicate. (05 Mar 2000) |
| calcium magnesium-atpase | <enzyme> An enzyme that catalyses the hydrolysis of ATP and is activated by millimolar concentrations of either calcium or magnesium. Unlike calcium-transporting atpase it does not require the second divalent cation for its activity, and is not sensitive to orthovanadate. Registry number: EC 3.6.1.- (12 Dec 1998) |
| calcium magnesium dependent endodeoxyribonuclease | <enzyme> Similar in action but different from dnase i Registry number: EC 3.1.21.- Synonym: ca mg dnase, ca(2+)+mg(2+) dnase, calcium-magnesium endonuclease, ca-mg endonuclease (26 Jun 1999) |
| magnesium | <chemical, element> An essential divalent cation. The major role is as the chelated ion in ATP and presumably other triphosphonucleotides. The magnesium ATP complex is the sole biologically active form of ATP. The other essential role of magnesium is as the central ion of chlorophyll. Cellular concentration is less than 5mM. Serum concentration approximately 1mM. Pharmacologic action: Hypomagnesemia can cause refractory ventricular fibrillation or ventricular tachycardia. Uses: known hypomagnesemic states - suspect hypomagnesmia in alcoholics, chronic disease states, or others with poor nutrition; treatment of choice for Torsade de Pointes. Dose: 1-2 grams IV push for cardiac arrest, over 1 to 2 minutes for Torsades, and over 5 to 60 minutes for acute myocardial infarction. Potential complications: Transient flushing and diaphoresis, sinus bradycardia, hypotension, hyporeflexia and paralysis with overdose. Abbreviation: Mg (15 Mar 2000) |